Renaissance Technologies
TCRT icon

Renaissance Technologies’s Alaunos Therapeutics TCRT Stock Holding History

Renaissance Technologies’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,547
Closed -$27K – 4070
2023
Q4 		$27K Buy
+2,547
New +$30.7K ﹤0.01% 3549
2023
Q3 		– Sell
-3,351
Closed -$256K – 4103
2023
Q2 		$256K Sell
3,351
-3,448
-51% -$279K ﹤0.01% 3193
2023
Q1 		$642K Sell
6,799
-3,726
-35% -$355K ﹤0.01% 2745
2022
Q4 		$1.02M Buy
+10,525
New +$1.53M ﹤0.01% 2518
2022
Q2 		– Sell
-6,400
Closed -$626K – 4566
2022
Q1 		$626K Buy
6,400
+3,014
+89% +$387K ﹤0.01% 3038
2021
Q4 		$554K Sell
3,386
-6,364
-65% -$1.4M ﹤0.01% 3028
2021
Q3 		$2.66M Buy
9,750
+3,482
+56% +$1.06M ﹤0.01% 1879
2021
Q2 		$2.48M Buy
6,268
+3,357
+115% +$1.57M ﹤0.01% 2106
2021
Q1 		$1.57M Buy
2,911
+2,687
+1,200% +$1.67M ﹤0.01% 2377
2020
Q4 		$85K Sell
224
-1,009
-82% -$401K ﹤0.01% 3272
2020
Q3 		$466K Buy
1,233
+895
+265% +$395K ﹤0.01% 2834
2020
Q2 		$167K Sell
338
-4,176
-93% -$1.86M ﹤0.01% 3195
2020
Q1 		$1.66M Buy
4,514
+4,420
+4,702% +$2.29M ﹤0.01% 2150
2019
Q4 		$66K Sell
94
-777
-89% -$535K ﹤0.01% 3364
2019
Q3 		$559K Sell
871
-504
-37% -$400K ﹤0.01% 2830
2019
Q2 		$1.2M Buy
+1,375
New +$946K ﹤0.01% 2601
2018
Q2 		– Sell
-1,602
Closed -$942K – 3527
2018
Q1 		$942K Buy
+1,602
New +$998K ﹤0.01% 2684
2016
Q4 		– Sell
-2,103
Closed -$1.78M – 3434
2016
Q3 		$1.78M Buy
+2,103
New +$1.69M ﹤0.01% 2259
2014
Q4 		– Sell
-1,789
Closed -$708K – 3118
2014
Q3 		$708K Buy
+1,789
New +$862K ﹤0.01% 2193
2014
Q2 		– Sell
-558
Closed -$384K – 2959
2014
Q1 		$384K Buy
+558
New +$374K ﹤0.01% 2442

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return

Renaissance Technologies's TCRT Position: Q1 2024 in Review

Renaissance Technologies sold out of Alaunos Therapeutics (TCRT) in Q1 2024, closing a stake of 2,547 shares — an estimated $27K sold.

Renaissance Technologies first reported a position in TCRT in Q1 2014 and held it in 20 quarters. The position peaked at $2.66M in Q3 2021. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.

  • Renaissance Technologies reported no remaining Alaunos Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Renaissance Technologies sold 2,547 Alaunos Therapeutics shares in Q1 2024, an estimated $27K.
  • Renaissance Technologies first reported a position in Alaunos Therapeutics in Q1 2014 and held it in 20 quarters.
  • Renaissance Technologies's Alaunos Therapeutics position peaked at $2.66M in Q3 2021.
  • 45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.

Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.